Global Radiopharmaceutical Market Insights, Forecast to 2029

Publisher Name :
Date: 22-Sep-2023
No. of pages: 113
Inquire Before Buying

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The global Radiopharmaceutical market is projected to grow from US$ 7347.9 million in 2023 to US$ 11660 million by 2029, at a Compound Annual Growth Rate (CAGR) of 8.0% during the forecast period.

The global Radiopharmaceutical top three manufacturers include the Bracco Imaging, Bayer and Mallinckrodt, with about 47% market shares. North America and Europe is the main consumption places, with a consumption market share nearly 45% and 27%.

Report Includes:

This report presents an overview of global market for Radiopharmaceutical, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Radiopharmaceutical, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Radiopharmaceutical, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radiopharmaceutical sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Radiopharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Radiopharmaceutical sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc.

By Company

- Bracco Imaging

- Bayer

- Mallinckrodt

- Nordion

- Triad Isotopes

- Lantheus

- IBA Group

- GE Healthcare

- China Isotope & Radiation

- Jubilant Pharma

- Eli Lilly

- Advanced Accelerator Applications

- SIEMENS

- Dongcheng

- Navidea

Segment by Type

- Actinium-225

- Lutetium-177

- Radium-223

- Holmium-166

- Other

Segment by Application

- Oncology

- Cardiology

- Other

Segment by Region

- US & Canada

- - U.S.

- - Canada

- China

- Asia (excluding China)

- - Japan

- - South Korea

- - China Taiwan

- Southeast Asia

- - India

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Middle East, Africa, Latin America

- - Brazil

- - Mexico

- - Turkey

- - Israel

- - GCC Countries

Chapter Outline

Chapter 1: Introduces the Report Scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Radiopharmaceutical in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceutical sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Global Radiopharmaceutical Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Radiopharmaceutical Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceutical Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceutical Sales Estimates and Forecasts 2018-2029
2.2 Global Radiopharmaceutical Revenue by Region
2.2.1 Global Radiopharmaceutical Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Radiopharmaceutical Revenue by Region (2018-2023)
2.2.3 Global Radiopharmaceutical Revenue by Region (2024-2029)
2.2.4 Global Radiopharmaceutical Revenue Market Share by Region (2018-2029)
2.3 Global Radiopharmaceutical Sales Estimates and Forecasts 2018-2029
2.4 Global Radiopharmaceutical Sales by Region
2.4.1 Global Radiopharmaceutical Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Radiopharmaceutical Sales by Region (2018-2023)
2.4.3 Global Radiopharmaceutical Sales by Region (2024-2029)
2.4.4 Global Radiopharmaceutical Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Radiopharmaceutical Sales by Manufacturers
3.1.1 Global Radiopharmaceutical Sales by Manufacturers (2018-2023)
3.1.2 Global Radiopharmaceutical Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Radiopharmaceutical in 2022
3.2 Global Radiopharmaceutical Revenue by Manufacturers
3.2.1 Global Radiopharmaceutical Revenue by Manufacturers (2018-2023)
3.2.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Radiopharmaceutical Revenue in 2022
3.3 Global Key Players of Radiopharmaceutical, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Radiopharmaceutical Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Radiopharmaceutical, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Radiopharmaceutical, Product Offered and Application
3.8 Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Radiopharmaceutical Sales by Type
4.1.1 Global Radiopharmaceutical Historical Sales by Type (2018-2023)
4.1.2 Global Radiopharmaceutical Forecasted Sales by Type (2024-2029)
4.1.3 Global Radiopharmaceutical Sales Market Share by Type (2018-2029)
4.2 Global Radiopharmaceutical Revenue by Type
4.2.1 Global Radiopharmaceutical Historical Revenue by Type (2018-2023)
4.2.2 Global Radiopharmaceutical Forecasted Revenue by Type (2024-2029)
4.2.3 Global Radiopharmaceutical Revenue Market Share by Type (2018-2029)
4.3 Global Radiopharmaceutical Price by Type
4.3.1 Global Radiopharmaceutical Price by Type (2018-2023)
4.3.2 Global Radiopharmaceutical Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Radiopharmaceutical Sales by Application
5.1.1 Global Radiopharmaceutical Historical Sales by Application (2018-2023)
5.1.2 Global Radiopharmaceutical Forecasted Sales by Application (2024-2029)
5.1.3 Global Radiopharmaceutical Sales Market Share by Application (2018-2029)
5.2 Global Radiopharmaceutical Revenue by Application
5.2.1 Global Radiopharmaceutical Historical Revenue by Application (2018-2023)
5.2.2 Global Radiopharmaceutical Forecasted Revenue by Application (2024-2029)
5.2.3 Global Radiopharmaceutical Revenue Market Share by Application (2018-2029)
5.3 Global Radiopharmaceutical Price by Application
5.3.1 Global Radiopharmaceutical Price by Application (2018-2023)
5.3.2 Global Radiopharmaceutical Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Radiopharmaceutical Market Size by Type
6.1.1 US & Canada Radiopharmaceutical Sales by Type (2018-2029)
6.1.2 US & Canada Radiopharmaceutical Revenue by Type (2018-2029)
6.2 US & Canada Radiopharmaceutical Market Size by Application
6.2.1 US & Canada Radiopharmaceutical Sales by Application (2018-2029)
6.2.2 US & Canada Radiopharmaceutical Revenue by Application (2018-2029)
6.3 US & Canada Radiopharmaceutical Market Size by Country
6.3.1 US & Canada Radiopharmaceutical Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Radiopharmaceutical Sales by Country (2018-2029)
6.3.3 US & Canada Radiopharmaceutical Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Radiopharmaceutical Market Size by Type
7.1.1 Europe Radiopharmaceutical Sales by Type (2018-2029)
7.1.2 Europe Radiopharmaceutical Revenue by Type (2018-2029)
7.2 Europe Radiopharmaceutical Market Size by Application
7.2.1 Europe Radiopharmaceutical Sales by Application (2018-2029)
7.2.2 Europe Radiopharmaceutical Revenue by Application (2018-2029)
7.3 Europe Radiopharmaceutical Market Size by Country
7.3.1 Europe Radiopharmaceutical Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Radiopharmaceutical Sales by Country (2018-2029)
7.3.3 Europe Radiopharmaceutical Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Radiopharmaceutical Market Size
8.1.1 China Radiopharmaceutical Sales (2018-2029)
8.1.2 China Radiopharmaceutical Revenue (2018-2029)
8.2 China Radiopharmaceutical Market Size by Application
8.2.1 China Radiopharmaceutical Sales by Application (2018-2029)
8.2.2 China Radiopharmaceutical Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Radiopharmaceutical Market Size by Type
9.1.1 Asia Radiopharmaceutical Sales by Type (2018-2029)
9.1.2 Asia Radiopharmaceutical Revenue by Type (2018-2029)
9.2 Asia Radiopharmaceutical Market Size by Application
9.2.1 Asia Radiopharmaceutical Sales by Application (2018-2029)
9.2.2 Asia Radiopharmaceutical Revenue by Application (2018-2029)
9.3 Asia Radiopharmaceutical Sales by Region
9.3.1 Asia Radiopharmaceutical Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Radiopharmaceutical Revenue by Region (2018-2029)
9.3.3 Asia Radiopharmaceutical Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Radiopharmaceutical Market Size by Type
10.1.1 Middle East, Africa and Latin America Radiopharmaceutical Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Radiopharmaceutical Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Radiopharmaceutical Market Size by Application
10.2.1 Middle East, Africa and Latin America Radiopharmaceutical Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Radiopharmaceutical Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Radiopharmaceutical Sales by Country
10.3.1 Middle East, Africa and Latin America Radiopharmaceutical Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Radiopharmaceutical Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Radiopharmaceutical Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Information
11.1.2 Bracco Imaging Overview
11.1.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Bracco Imaging Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bracco Imaging Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Bayer Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Information
11.3.2 Mallinckrodt Overview
11.3.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Mallinckrodt Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mallinckrodt Recent Developments
11.4 Nordion
11.4.1 Nordion Company Information
11.4.2 Nordion Overview
11.4.3 Nordion Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Nordion Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nordion Recent Developments
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Information
11.5.2 Triad Isotopes Overview
11.5.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Triad Isotopes Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Triad Isotopes Recent Developments
11.6 Lantheus
11.6.1 Lantheus Company Information
11.6.2 Lantheus Overview
11.6.3 Lantheus Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Lantheus Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lantheus Recent Developments
11.7 IBA Group
11.7.1 IBA Group Company Information
11.7.2 IBA Group Overview
11.7.3 IBA Group Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 IBA Group Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 IBA Group Recent Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Company Information
11.8.2 GE Healthcare Overview
11.8.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 GE Healthcare Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GE Healthcare Recent Developments
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Company Information
11.9.2 China Isotope & Radiation Overview
11.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 China Isotope & Radiation Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 China Isotope & Radiation Recent Developments
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Company Information
11.10.2 Jubilant Pharma Overview
11.10.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Jubilant Pharma Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jubilant Pharma Recent Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Information
11.11.2 Eli Lilly Overview
11.11.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Eli Lilly Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Eli Lilly Recent Developments
11.12 Advanced Accelerator Applications
11.12.1 Advanced Accelerator Applications Company Information
11.12.2 Advanced Accelerator Applications Overview
11.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Advanced Accelerator Applications Recent Developments
11.13 SIEMENS
11.13.1 SIEMENS Company Information
11.13.2 SIEMENS Overview
11.13.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 SIEMENS Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 SIEMENS Recent Developments
11.14 Dongcheng
11.14.1 Dongcheng Company Information
11.14.2 Dongcheng Overview
11.14.3 Dongcheng Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Dongcheng Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Dongcheng Recent Developments
11.15 Navidea
11.15.1 Navidea Company Information
11.15.2 Navidea Overview
11.15.3 Navidea Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Navidea Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Navidea Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Radiopharmaceutical Industry Chain Analysis
12.2 Radiopharmaceutical Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Radiopharmaceutical Production Mode & Process
12.4 Radiopharmaceutical Sales and Marketing
12.4.1 Radiopharmaceutical Sales Channels
12.4.2 Radiopharmaceutical Distributors
12.5 Radiopharmaceutical Customers
13 Market Dynamics
13.1 Radiopharmaceutical Industry Trends
13.2 Radiopharmaceutical Market Drivers
13.3 Radiopharmaceutical Market Challenges
13.4 Radiopharmaceutical Market Restraints
14 Key Findings in The Global Radiopharmaceutical Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Radiopharmaceutical Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Actinium-225
Table 3. Major Manufacturers of Lutetium-177
Table 4. Major Manufacturers of Radium-223
Table 5. Major Manufacturers of Holmium-166
Table 6. Major Manufacturers of Other
Table 7. Global Radiopharmaceutical Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Radiopharmaceutical Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Radiopharmaceutical Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Radiopharmaceutical Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Radiopharmaceutical Revenue Market Share by Region (2018-2023)
Table 12. Global Radiopharmaceutical Revenue Market Share by Region (2024-2029)
Table 13. Global Radiopharmaceutical Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Radiopharmaceutical Sales by Region (2018-2023) & (M Doses)
Table 15. Global Radiopharmaceutical Sales by Region (2024-2029) & (M Doses)
Table 16. Global Radiopharmaceutical Sales Market Share by Region (2018-2023)
Table 17. Global Radiopharmaceutical Sales Market Share by Region (2024-2029)
Table 18. Global Radiopharmaceutical Sales by Manufacturers (2018-2023) & (M Doses)
Table 19. Global Radiopharmaceutical Sales Share by Manufacturers (2018-2023)
Table 20. Global Radiopharmaceutical Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Radiopharmaceutical Revenue Share by Manufacturers (2018-2023)
Table 22. Global Key Players of Radiopharmaceutical, Industry Ranking, 2021 VS 2022 VS 2023
Table 23. Radiopharmaceutical Price by Manufacturers 2018-2023 (USD/Dose)
Table 24. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2022)
Table 26. Global Key Manufacturers of Radiopharmaceutical, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Radiopharmaceutical, Product Offered and Application
Table 28. Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Radiopharmaceutical Sales by Type (2018-2023) & (M Doses)
Table 31. Global Radiopharmaceutical Sales by Type (2024-2029) & (M Doses)
Table 32. Global Radiopharmaceutical Sales Share by Type (2018-2023)
Table 33. Global Radiopharmaceutical Sales Share by Type (2024-2029)
Table 34. Global Radiopharmaceutical Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Radiopharmaceutical Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Radiopharmaceutical Revenue Share by Type (2018-2023)
Table 37. Global Radiopharmaceutical Revenue Share by Type (2024-2029)
Table 38. Radiopharmaceutical Price by Type (2018-2023) & (USD/Dose)
Table 39. Global Radiopharmaceutical Price Forecast by Type (2024-2029) & (USD/Dose)
Table 40. Global Radiopharmaceutical Sales by Application (2018-2023) & (M Doses)
Table 41. Global Radiopharmaceutical Sales by Application (2024-2029) & (M Doses)
Table 42. Global Radiopharmaceutical Sales Share by Application (2018-2023)
Table 43. Global Radiopharmaceutical Sales Share by Application (2024-2029)
Table 44. Global Radiopharmaceutical Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Radiopharmaceutical Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Radiopharmaceutical Revenue Share by Application (2018-2023)
Table 47. Global Radiopharmaceutical Revenue Share by Application (2024-2029)
Table 48. Radiopharmaceutical Price by Application (2018-2023) & (USD/Dose)
Table 49. Global Radiopharmaceutical Price Forecast by Application (2024-2029) & (USD/Dose)
Table 50. US & Canada Radiopharmaceutical Sales by Type (2018-2023) & (M Doses)
Table 51. US & Canada Radiopharmaceutical Sales by Type (2024-2029) & (M Doses)
Table 52. US & Canada Radiopharmaceutical Revenue by Type (2018-2023) & (US$ Million)
Table 53. US & Canada Radiopharmaceutical Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Radiopharmaceutical Sales by Application (2018-2023) & (M Doses)
Table 55. US & Canada Radiopharmaceutical Sales by Application (2024-2029) & (M Doses)
Table 56. US & Canada Radiopharmaceutical Revenue by Application (2018-2023) & (US$ Million)
Table 57. US & Canada Radiopharmaceutical Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Radiopharmaceutical Revenue by Country (2018-2023) & (US$ Million)
Table 60. US & Canada Radiopharmaceutical Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Radiopharmaceutical Sales by Country (2018-2023) & (M Doses)
Table 62. US & Canada Radiopharmaceutical Sales by Country (2024-2029) & (M Doses)
Table 63. Europe Radiopharmaceutical Sales by Type (2018-2023) & (M Doses)
Table 64. Europe Radiopharmaceutical Sales by Type (2024-2029) & (M Doses)
Table 65. Europe Radiopharmaceutical Revenue by Type (2018-2023) & (US$ Million)
Table 66. Europe Radiopharmaceutical Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Radiopharmaceutical Sales by Application (2018-2023) & (M Doses)
Table 68. Europe Radiopharmaceutical Sales by Application (2024-2029) & (M Doses)
Table 69. Europe Radiopharmaceutical Revenue by Application (2018-2023) & (US$ Million)
Table 70. Europe Radiopharmaceutical Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Radiopharmaceutical Revenue by Country (2018-2023) & (US$ Million)
Table 73. Europe Radiopharmaceutical Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Radiopharmaceutical Sales by Country (2018-2023) & (M Doses)
Table 75. Europe Radiopharmaceutical Sales by Country (2024-2029) & (M Doses)
Table 76. China Radiopharmaceutical Sales by Type (2018-2023) & (M Doses)
Table 77. China Radiopharmaceutical Sales by Type (2024-2029) & (M Doses)
Table 78. China Radiopharmaceutical Revenue by Type (2018-2023) & (US$ Million)
Table 79. China Radiopharmaceutical Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Radiopharmaceutical Sales by Application (2018-2023) & (M Doses)
Table 81. China Radiopharmaceutical Sales by Application (2024-2029) & (M Doses)
Table 82. China Radiopharmaceutical Revenue by Application (2018-2023) & (US$ Million)
Table 83. China Radiopharmaceutical Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Radiopharmaceutical Sales by Type (2018-2023) & (M Doses)
Table 85. Asia Radiopharmaceutical Sales by Type (2024-2029) & (M Doses)
Table 86. Asia Radiopharmaceutical Revenue by Type (2018-2023) & (US$ Million)
Table 87. Asia Radiopharmaceutical Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Radiopharmaceutical Sales by Application (2018-2023) & (M Doses)
Table 89. Asia Radiopharmaceutical Sales by Application (2024-2029) & (M Doses)
Table 90. Asia Radiopharmaceutical Revenue by Application (2018-2023) & (US$ Million)
Table 91. Asia Radiopharmaceutical Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Radiopharmaceutical Revenue by Region (2018-2023) & (US$ Million)
Table 94. Asia Radiopharmaceutical Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Radiopharmaceutical Sales by Region (2018-2023) & (M Doses)
Table 96. Asia Radiopharmaceutical Sales by Region (2024-2029) & (M Doses)
Table 97. Middle East, Africa and Latin America Radiopharmaceutical Sales by Type (2018-2023) & (M Doses)
Table 98. Middle East, Africa and Latin America Radiopharmaceutical Sales by Type (2024-2029) & (M Doses)
Table 99. Middle East, Africa and Latin America Radiopharmaceutical Revenue by Type (2018-2023) & (US$ Million)
Table 100. Middle East, Africa and Latin America Radiopharmaceutical Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Radiopharmaceutical Sales by Application (2018-2023) & (M Doses)
Table 102. Middle East, Africa and Latin America Radiopharmaceutical Sales by Application (2024-2029) & (M Doses)
Table 103. Middle East, Africa and Latin America Radiopharmaceutical Revenue by Application (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Radiopharmaceutical Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Radiopharmaceutical Revenue by Country (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Radiopharmaceutical Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Radiopharmaceutical Sales by Country (2018-2023) & (M Doses)
Table 109. Middle East, Africa and Latin America Radiopharmaceutical Sales by Country (2024-2029) & (M Doses)
Table 110. Bracco Imaging Company Information
Table 111. Bracco Imaging Description and Major Businesses
Table 112. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 113. Bracco Imaging Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bracco Imaging Recent Developments
Table 115. Bayer Company Information
Table 116. Bayer Description and Major Businesses
Table 117. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 118. Bayer Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bayer Recent Developments
Table 120. Mallinckrodt Company Information
Table 121. Mallinckrodt Description and Major Businesses
Table 122. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 123. Mallinckrodt Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Mallinckrodt Recent Developments
Table 125. Nordion Company Information
Table 126. Nordion Description and Major Businesses
Table 127. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 128. Nordion Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Nordion Recent Developments
Table 130. Triad Isotopes Company Information
Table 131. Triad Isotopes Description and Major Businesses
Table 132. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 133. Triad Isotopes Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Triad Isotopes Recent Developments
Table 135. Lantheus Company Information
Table 136. Lantheus Description and Major Businesses
Table 137. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 138. Lantheus Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Lantheus Recent Developments
Table 140. IBA Group Company Information
Table 141. IBA Group Description and Major Businesses
Table 142. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 143. IBA Group Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. IBA Group Recent Developments
Table 145. GE Healthcare Company Information
Table 146. GE Healthcare Description and Major Businesses
Table 147. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 148. GE Healthcare Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. GE Healthcare Recent Developments
Table 150. China Isotope & Radiation Company Information
Table 151. China Isotope & Radiation Description and Major Businesses
Table 152. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 153. China Isotope & Radiation Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. China Isotope & Radiation Recent Developments
Table 155. Jubilant Pharma Company Information
Table 156. Jubilant Pharma Description and Major Businesses
Table 157. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 158. Jubilant Pharma Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Jubilant Pharma Recent Developments
Table 160. Eli Lilly Company Information
Table 161. Eli Lilly Description and Major Businesses
Table 162. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 163. Eli Lilly Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Eli Lilly Recent Developments
Table 165. Advanced Accelerator Applications Company Information
Table 166. Advanced Accelerator Applications Description and Major Businesses
Table 167. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 168. Advanced Accelerator Applications Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Advanced Accelerator Applications Recent Developments
Table 170. SIEMENS Company Information
Table 171. SIEMENS Description and Major Businesses
Table 172. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 173. SIEMENS Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. SIEMENS Recent Developments
Table 175. Dongcheng Company Information
Table 176. Dongcheng Description and Major Businesses
Table 177. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 178. Dongcheng Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Dongcheng Recent Developments
Table 180. Navidea Company Information
Table 181. Navidea Description and Major Businesses
Table 182. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 183. Navidea Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Navidea Recent Developments
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Radiopharmaceutical Distributors List
Table 188. Radiopharmaceutical Customers List
Table 189. Radiopharmaceutical Market Trends
Table 190. Radiopharmaceutical Market Drivers
Table 191. Radiopharmaceutical Market Challenges
Table 192. Radiopharmaceutical Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Product Picture
Figure 2. Global Radiopharmaceutical Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Radiopharmaceutical Market Share by Type in 2022 & 2029
Figure 4. Actinium-225 Product Picture
Figure 5. Lutetium-177 Product Picture
Figure 6. Radium-223 Product Picture
Figure 7. Holmium-166 Product Picture
Figure 8. Other Product Picture
Figure 9. Global Radiopharmaceutical Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Radiopharmaceutical Market Share by Application in 2022 & 2029
Figure 11. Oncology
Figure 12. Cardiology
Figure 13. Other
Figure 14. Radiopharmaceutical Report Years Considere
  • Global Radiopharmaceutical Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, produ......
  • Global Radiopharmaceuticals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138
    According to our LPI (LP Information) latest study, the global Radiopharmaceuticals market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceuticals is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceuticals market. Radiopharmaceuticals are expected to show stable growth in the future market. However, p......
  • Global Radiopharmaceutical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 137
    According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule con......
  • Global Radiation Dose Management Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 88
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiation Dose Management market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Landauer - Sectra AB - Afga-Gevaert - INFINITT Healthcare - Bayer Healthcare - PACSHealth - Koninklijke Philips - GE Healthcar......
  • Global Radiation Dose Management Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global Radiation Dose Management market: According to our latest research, the global Radiation Dose Management market looks promising in the next 5 years. As of 2022, the global Radiation Dose Management market was estimated at USD 484.67 million, and it's anticipated to reach USD 1069.95 million in 2028, with a CAGR of 14.11% during the forecast years. The radiation dose management channel includes information of radiation dose recording software, real-ti......
  • Global Radiation Dose Management Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: The Global Radiation Dose Management Market Size was estimated at USD 862.70 million in 2022 and is projected to reach USD 3695.44 million by 2029, exhibiting a CAGR of 23.10% during the forecast period. This report provides a deep insight into the global Radiation Dose Management market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......
  • Global Radiopharmaceutical Professional Survey Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 133
    Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......
  • Global Radiopharmaceutical Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166
    Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......
  • Global Radiopharmaceutical Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Nov-2023        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global Radiopharmaceutical market: According to our latest research, the global Radiopharmaceutical market looks promising in the next 5 years. As of 2022, the global Radiopharmaceutical market was estimated at USD 7319.21 million, and it's anticipated to reach USD 13640.5 million in 2028, with a CAGR of 10.93% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global R......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs